| abstract |
the invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1s, 3r, 4r, 5r) -3 - {[(2e) - 3- (3,4-dihydroxy-phenyl) -2-propenoyl] oxy} -1,4,5-trihydroxy-cyclohexane-carboxylic and do (2s, 3e, 4s) -4- {2- [2- (3,4-dihydroxy-phenyl) ethoxy] -2-oxo- methyl} -3-ethylidene-2- (ß-d-glycopyran-siloxy) -3,4-dihydro-2h-pyran-5-carboxylate for use as a drug or veterinary product, particularly in prevention and / or treatment of pathological disorders of carbohydrate and / or lipid metabolism. |